Davidson News

Davidson News

FDA Approves RSV Vaccine For Adults Aged 50 and Over

Washington Post

The U.S. Food and Drug Administration (FDA) has approved GSK’s respiratory syncytial virus (RSV) vaccine for adults aged 50 and older who are at higher risk of severe RSV. This makes it the first RSV vaccine authorized for this age group. Previously, the vaccine was only approved for adults 60 and older. Clinical Trials and … Read more

COVID-19 Remains Most Lethal, but Flu and RSV Pose Growing Threats Across US

Health Officials Monitor Rising Respiratory Infections Amid Flu Season As the United States grapples with a surge in respiratory illnesses, health officials warn of the increasing impact of influenza and respiratory syncytial virus (RSV). While flu cases gain momentum and RSV infections reach their peak in certain regions, COVID-19 continues to exert the most significant … Read more